100 likes | 365 Views
Delivering Guidelines for COPD and Pharma Partnership. Dr Ninian Hewitt Clinical Lead for Lothian Respiratory (COPD) MCN. Lothian COPD Guidelines . Why? Patients needed better care and healthcare professionals needed concise and up-to-date information
E N D
Delivering Guidelines for COPDandPharma Partnership Dr Ninian Hewitt Clinical Lead for Lothian Respiratory (COPD) MCN
Lothian COPD Guidelines Why? • Patients needed better care and healthcare professionals needed concise and up-to-date information • Outcome – Patients with COPD will receive the best possible care
Lothian COPD Guidelines Who? • Patients and carers were involved from the beginning. They gave their opinions and advice about: • The treatment they would like • Issues they felt needed to be addressed • Terminology discrepancies • We also consulted a wide range of healthcare professionals including consultants, pharmacists, physiotherapists, physiologists, specialist nurses, GPs, stop smoking facilitators and many more
What? Diagnosis Risk factors Chest x-ray A1 antitrypsin deficiency Co-morbidities Treatment Delivery systems Pulmonary rehabilitation Exacerbations Referral to consultant Discharge and follow-up Palliative care Travelling with COPD Help agencies for patients and carers Patient information Contact information Primary care exacerbation protocol Pulmonary rehabilitation referral form COPD self-management plan Lothian COPD Guidelines
Lothian COPD Guidelines • Lothian wide • Includes an FAQ section • Based on GOLD definitions • Equality and diversity rapid impact assessment performed
Lothian COPD Guidelines How? • Meetings were held in each CHP to introduce the guidelines along with educational sessions on spirometry and treatment. These were attended by almost 200 healthcare professionals • Secondary care meetings will be held in each of the three main hospitals to discuss the guidelines • An audit will be performed in 2010
Partnership with ABPI Scotland • Guided by the Scottish Executive document A Common Understanding – Guidance on Joint Working Between NHS Scotland and the Pharmaceutical Industry • Participating under the umbrella of ABPI Scotland; AstraZeneca, Boehringer Ingelheim, Chiesi, GlaxoSmithKline, and Pfizer
Partnership with ABPI Scotland • Monthly meetings held between ABPI companies and MCN management • ABPI companies offer support and resources but do not make decisions for the MCN • ABPI companies have no input in treatment recommendations • They have been extremely helpful with event organising, social marketing and project managing
Lothian Respiratory (COPD) MCN Thank you